YAP1 and nonpapillary renal cell carcinoma: Additionally, YAP inhibits NF-κB pathway and ccRCC growth by opposing zinc fingers and homeoboxes protein 2 (ZHX2), a critical p65 co-activator, further demonstrating its tumor-suppressive role in ccRCC (Li et al., 2025).